Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation.

Yury A Surovoy Maksim A Burkin Inna A Galvidis Pavel O Bochkov Armen V Oganesyan Sergei V Tsarenko

Published in: The Journal of antimicrobial chemotherapy (2022)

Currently recommended polymyxin B dosage regimens are sufficient for patients receiving ECMO and no dosage increase is required. In our study, polymyxin B exposure was higher in ECMO patients compared with the control group.

Keyphrases

extracorporeal membrane oxygenation
acute respiratory distress syndrome
respiratory failure
end stage renal disease
gram negative
ejection fraction
newly diagnosed
chronic kidney disease
mechanical ventilation
peritoneal dialysis
intensive care unit
patient reported